T0	MultiCitation 6039 6043	[32]
T1	MultiCitation 26100 26104	[32]
T2	MultiCitation 27375 27379	[32]
T3	Span 5849 6044	The 3xTg-AD15-18 mice were treated for 3 months based on previous studies showing that in young mice 10-12 weeks of rapamycin administration is sufficient to reduce soluble Aβ and tau [29], [32].
R1	Context Target:T0 Context:T3	
T4	Span 25929 26105	We, and others, have previously shown that rapamycin reduces soluble Aβ and tau pathology and the associated early cognitive deficits in 6-month-old transgenic mice [29], [32].
R2	Context Target:T1 Context:T4	
T5	Span 27285 27410	Data in apparent contradiction to each other have been also reported by others [5], [29], [32], [71], [72], [73], [74], [75].
R3	Context Target:T2 Context:T5	
